Paulina Tran
Family · Carrollton, TXNPI 1073217675
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 237 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$805
- Novo Nordisk$369
- Otsuka America Pharmaceutical, Inc.$351
- Pfizer$343
- Lilly USA, LLC$298
- Corcept Therapeutics$296
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,648100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $805 |
| Novo Nordisk | 20 | $369 |
| Otsuka America Pharmaceutical, Inc. | 19 | $351 |
| Pfizer | 18 | $343 |
| Lilly USA, LLC | 19 | $298 |
| Corcept Therapeutics | 9 | $296 |
| Abbott | 8 | $289 |
| Bayer | 10 | $253 |
| Astellas Pharma US Inc | 5 | $192 |
| AstraZeneca | 6 | $186 |
| Amgen | 10 | $175 |
| GSK | 7 | $154 |
| Supernus Pharmaceuticals, Inc. | 4 | $145 |
| Sanofi-aventis U.S. LLC | 5 | $101 |
| Kowa Pharmaceuticals America, Inc. | 5 | $87 |
| Exact Sciences | 4 | $74 |
| Dexcom, Inc. | 3 | $55 |
| Biotronik NRO, Inc. | 1 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Boehringer Ingelheim | 3 | $51 |
| Axsome Therapeutics, Inc. | 3 | $49 |
| Madrigal Pharmaceuticals | 2 | $39 |
| Medtronic | 2 | $38 |
| Lundbeck LLC | 2 | $38 |
| Corium, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $23 |
| Merck | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Tolmar, Inc. | 1 | $14 |
| Intuity Medical Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$133
- QULIPTA$125
- UBRELVY$125
- Kerendia$122
- Veozah$113
How this compares
$4,648 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 13 | $256 |
| Atorvastatin Calcium | 30 | $195 |
| Metoprolol Succinate | 12 | $182 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $154 |
| Amlodipine Besylate | 15 | $126 |
| Rosuvastatin Calcium | 17 | $93 |
| Levothyroxine Sodium | 13 | $74 |
Paid to pharmacies, not to this prescriber.
Other family in Carrollton
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.